Broeders, M E <br/><br/>
Verapamil causes decreased diaphragm endurance but no decrease of nocturnal O(2) saturation in patients with chronic obstructive pulmonary disease.  [electronic resource] 

 -  European journal of clinical pharmacology  Jan 2000 
 - 729-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/s002280050005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Gas Analysis<br/>Calcium Channel Blockers--pharmacology<br/>Circadian Rhythm--physiology<br/>Cross-Over Studies<br/>Diaphragm--drug effects<br/>Double-Blind Method<br/>Drug Interactions<br/>Humans<br/>Lung Diseases, Obstructive--metabolism<br/>Middle Aged<br/>Muscle Contraction--drug effects<br/>Muscle, Skeletal--drug effects<br/>Oxygen--metabolism<br/>Placebos<br/>Theophylline--pharmacology<br/>Vasodilator Agents--pharmacology<br/>Verapamil--pharmacology